LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
28/07/2026
Voltar para busca
Dado oficial do USPTO
BICLONICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BICLONICS
ST13
US500000079127665Classe
1, 5, 42
Pedido
79127665
Registro
4468374
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
55
Atualização mais recente
28/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
10/12/2012
Data de registro
21/01/2014
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/11/2024
Última transação
28/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
98
Localização do titular
NL
Examinador
DALIER, JOHN DAVID
Localização atual
Historical data usage
Titulares e representantes
Titulares
Merus B.V.
Merus N.V.
Merus B.V.
Representantes
Max Vern Amster, Rothstein & Ebenstein LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biochemical products used in industry and scienceantibodiesbeing protein mixtures for use in industry and science
Classe 5
Pharmaceutical and veterinary preparations wholly or partly produced with antibodies for the treatment of infections neutralization and removal of cytokines and chemokines related to disorders of inflammation and abnormal cell growthtumor cell killing
Classe 42
Biochemist services; bacteriologic and biochemical laboratory research and testing servicesconsulting services related thereto; scientific consulting for industry and government servicesproviding scientific reports by scientistsengineersanalysts and laboratory assistants and technicians in the field of antibodiesbeing protein mixtures used in industry and science; scientific and industrial research in the field of antibodies being protein mixtures used in industry and scienceespecially characterizing the aforementioned antibodies; research and development of new products for third partiesin particular characterized in the aforementioned antibodies
Publicações
Histórico de despachos e eventos da marca no USPTO.
55 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/05/2026
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
28/05/2026
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
28/05/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/05/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/05/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28/05/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
28/05/2026
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
07/05/2026
CHLD
CHANGE OF OWNER RECEIVED FROM IB
19/03/2026
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
27/11/2024
71AG
REGISTERED-SEC.71 ACCEPTED
27/11/2024
PR71
POST REGISTRATION ACTION MAILED - SEC.71
24/10/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
07/10/2024
PR71
POST REGISTRATION ACTION MAILED - SEC.71
12/09/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/09/2024
ES71
TEAS SECTION 71 RECEIVED
04/12/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
16/06/2023
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
21/01/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
17/12/2022
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
18/09/2020
71AG
REGISTERED-SEC.71 ACCEPTED
18/09/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
15/09/2020
PR71
POST REGISTRATION ACTION MAILED - SEC.71
14/09/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/09/2020
PR71
POST REGISTRATION ACTION MAILED - SEC.71
05/03/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/03/2020
ES71
TEAS SECTION 71 RECEIVED
14/01/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/03/2019
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
21/01/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
26/10/2017
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
13/06/2014
FICS
FINAL DISPOSITION NOTICE SENT TO IB
28/05/2014
FIMP
FINAL DISPOSITION PROCESSED
28/05/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
21/04/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
21/01/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/11/2013
PUBO
PUBLISHED FOR OPPOSITION
05/11/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
16/10/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/10/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/09/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/09/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/09/2013
ALIE
ASSIGNED TO LIE
18/09/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/09/2013
RFNT
REFUSAL PROCESSED BY IB
07/05/2013
MAFR
APPLICATION FILING RECEIPT MAILED
19/04/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/04/2013
RFRR
REFUSAL PROCESSED BY MPU
18/04/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/04/2013
CNRT
NON-FINAL ACTION WRITTEN
17/04/2013
DOCK
ASSIGNED TO EXAMINER
15/04/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/04/2013
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/04/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/04/2013
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BICLONICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.